Eqvalan 18.7 mg/g pâte orale pour chevaux
Eqvalan 18.7 mg/g pâte orale pour chevaux
Authorised
- Ivermectin
Product identification
Medicine name:
Eqvalan 18.7 mg/g pâte orale pour chevaux
Active substance:
- Ivermectin
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ivermectin18.70/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal16day
-
Milkno withdrawal periodDo not use in animals producing milk for human consumption
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Package description:
- Eqvalan 50 x 8.03 g Pre-filled syringes Oral paste
- Eqvalan 50 x 6.42 g Pre-filled syringes Oral paste
- Eqvalan 50 x 11.77 g Pre-filled syringes Oral paste
- Eqvalan 11.77 g Pre-filled syringe Oral paste
- Eqvalan 8.03 g Pre-filled syringe Oral paste
- Eqvalan 6.42 g Pre-filled syringe Oral paste
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Health
Authorisation number:
- V 344/98/02/0023
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/03/2023
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/03/2023